Inside Medscape’s Medical AI Platform for Clinicians

Healthcare providers are drowning in information. 

With medical knowledge doubling every few months and clinical guidelines constantly evolving, doctors face the challenge of keeping pace while still finding time to see patients. 

More than 80% now use or plan to implement AI tools in their practices, while the healthcare AI market is projected to reach US$868bn by 2030, according to consultancy PwC.

Medscape, a digital platform for healthcare professionals owned by Internet Brands, has launched Medscape AI to cut through the noise. 

The tool provides clinical decision support to 13 million members worldwide, combining Medscape’s proprietary medical content with evidence from more than 400 peer-reviewed journals across specialties including oncology, cardiology, internal medicine and dermatology.

Bob Brisco, CEO of Internet Brands, says: “As AI becomes essential to modern clinical practice, it not only needs to unlock unmatched value to our users, it must also meet the rigorous standards clinicians require: accurate, current and evidence-based.

“Medscape AI delivers this and more.”

Unlike general-purpose AI tools that pull from the open internet, Medscape AI traces every response back to verified source material. 

The platform excludes unverified content, instead relying on human-validated medical expertise and peer-reviewed research. 

For clinicians who need to trust the information they’re acting on, that distinction matters.

How Medscape AI synthesises clinical evidence in real time

Medscape operates as a subsidiary of WebMD Health Corp and provides specialty hubs and continuing medical education courses across more than 30 medical areas. 

The company’s new AI tool integrates real-time updates on medical research, clinical guidelines and treatment protocols, with all content undergoing editorial supervision before publication.

Bob describes the system as a response to information overload: “It cuts through the information overload plaguing healthcare professionals, synthesising evidence instantly to drive better patient outcomes,” he says.

“It’s clinical precision in your pocket – expert guidance that’s tailored to meet your exact query, grounded in evidence and powered by Medscape’s human-validated compendium of medical expertise.”

Dr Kevin Fernando, FRCGP FRCP Edin. FAcadMEd MSc Diabetes, has used Medscape since his medical school days nearly three decades ago. He sees the AI tool as a natural evolution of the platform.

“The global launch of Medscape AI puts clinicians at the forefront of innovation,” he says. 

“Rapid access to trusted, human-validated expert content will improve clinical practice and elevate patient care for me and my colleagues across Europe and beyond.”

How time savings translate to better patient care

The tool operates across diagnosis, treatment planning and patient care workflows, linking into Medscape’s existing newsreader and point-of-care support tools. 

The company provides access to all members regardless of location or language, positioning the platform as a resource for clinicians working in vastly different healthcare systems.

F Perry Willson, MD, MSCE, a nephrologist at Yale New Haven Hospital, has put the platform through its paces in clinical practice. His priorities reflect what most doctors want from AI tools.

“The things I am looking for when I’m interacting with tools like this are reliability and verifiability – having verifiable information increases my ability to trust what I am seeing,” he says.

For Perry, the citation system makes the difference between a tool he might use and one he actually relies on. 

“Everything that Medscape AI says is going to be tied back to something that you can click on and see the primary source,” he says. 

“A model like this saves me time, which means I have more time to take care of my patients and get home and spend time with my family.”